Apolipoprotein EA (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro

Brain Research

Volumn 749, Issue 1, 1997, Pages 135-138

  McGeer, Patrick L ^a   Walker, Douglas G ^a   Pitas, Robert E ^b   Mahley, Robert W ^b   McGeer, Edith G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Binding; Inflammation; Senile plaque

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BINDING; SENILE PLAQUE; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COMPLEMENT ACTIVATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS;

EID: 0030615198     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01324-8     Document Type: Article

References (21)

1. Arai, H., Muramatsu, T., Higuchi, S., Sasaki, H. and Trojanowski, J.Q., Apolipoprotein E gene in Parkinson's disease with or without dementia, Lancet, 344 (1994) 889.
2. Gearing, M., Schneider, J.A., Robbing, R.S., Hollister, R.D., Mori, H., Games, D., Hyman, B.T. and Mirra, S.S., Regional variation in the distribution of apolipoprotein E and A β in Alzheimer's disease, J. Neuropathol. Exp. Neurol., 54 (1995) 833-841.
3. Innerarity, T.L., Pitas, R.E. and Mahley, R.W., Lipoprotein-receptor interactions, Methods Enzymol., 129 (1986) 542-565.
4. Jiang, H., Burdick, D., Glabe, G.G., Cotman, C.W. and Tenner, A.J., β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the Clq A chain, J. Immunol., 152(1994)5050-5059.
5. Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature, 227 (1970) 680-685.
6. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951)265-275.
7. Mahley, R.W., Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science, 240 (1988) 622-630.
8. McGeer, P.L. and McGeer, E.G., The inflammatory response system of brain: implications for therapy of Alzheimer and other neurode-generative diseases, Brain Res. Rev., 21 (1995) 195-218.
9. McGeer, P.L. and Rogers, J., Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease, Neurology, 42 (1992) 447-449.
10. McGeer, P.L., Schulzer, M. and McGeer, E.G., Arthritis and anti-inflammatory agents as negative risk factors for Alzheimer disease: a review of seventeen epidemiological studies, Neurology, 47 (1996) 425-432.
11. Mui, S., Rebeck, G.W., McKenna-Yasek, D., Hyman, B.T. and Brown, Jr., R.H., Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis, Ann. Neurol., 38 (1995) 460-463.
12. Myers, R.H., Schaefer, E.J., Wilson, P.W.F., D'Agostino, R., Ordovas, J.M., Espino, A., Au, R., White, R.F., Knoefel, J.E., Cobb, J.L., McNulty, K.A., Beiser, A. and Wolf, P.A., Apolipoprotein E ε4 association with dementia in a population-based study: the Framingham study, Neurology, 46 (1996) 673-677.
13. Rall Jr., S.C., Weisgraber, K.H., Innerarity, T.L., Bersot, T.P., Mahley, R.W. and Blum, C.B., Identification of a new structural variant of human apolipoprotein E, E2 (Lys 146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype, J. Clin. Invest., 12 (1983) 1288-1297.
14. Rall Jr., S.C., Weisgraber, K.H. and Mahley, R.W., Isolation and characterization of apolipoprotein E, Methods Enzymol., 128 (1986) 273-287.
15. Rogers, J., Cooper, N.R., Webster, S., Schultz, J., McGeer, P.L., Styren, S., Civin, W.H., Brachova, L., Bradt, B., Ward, P. and Lieberburg, I., Complement activation by β-amyloid in Alzheimer disease, Proc. Natl. Acad. Sci. USA, 89 (1992) 10016-10020.
16. Saunders, A.M., Schmader, K., Breitner, J.S., Benson, M.D., Brown, W.T., Goldfard, L., Goldgaber, D., Manwaring, M.G., Szymanski, M.H., McCown, N., Dole, K.C., Schmechel, D.E., Strittmatter, W.J., Pericak-Vance, M.A. and Roses, A.D., Apolipoprotein E ε4 distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases, Lancet, 342 (1993) 710-711.
17. Strittmatter, W.J. and Roses, A.D., Apolipoprotein E and Alzheimer's disease, Annu. Rev. Neurosci., 19 (1996) 53-77.
18. Strittmatter, W.J., Saunders, A., Schmechel, D., Perjcak-Vance, M., Enghild, J., Salvesens, G.S. and Roses, A.D., Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 1977-1981.
19. Strittmatter, W.J., Weisgraber, K.H., Huang, D.Y., Dong, L.-M., Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D., Binding of human apolipoprotein E to synthetic amyloid β-peptide: isoform-specific effects and implications for late-onset Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90 (1993) 8098-8102.
20. Tabaton, M., Rolleri, M., Masturzo, P., Cammarata, S., Angelini, G., Hansen, L.A., Saitoh, T., Petersen, R.B., Perry, G. and Richey, P., Apolipoprotein E ε4 allele frequency is not increased in progressive supranuclear palsy, Neurology, 45 (1995) 1764-1765.
21. Waring, S.C., O'Brien, P.C., Kurland, L.T., Thibodeau, S.N., Teal, M.-S., Petersen, R.C. and Esteban-Santillan, C.E., Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex. Lancet, 343 (1994) 611.